Literature DB >> 17391006

Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.

Nathan F Bouxsein1, Christopher S McAllister, Kai K Ewert, Charles E Samuel, Cyrus R Safinya.   

Abstract

Small interfering RNAs (siRNAs) of 19-25 bp mediate the cleavage of complementary mRNA, leading to post-transcriptional gene silencing. We examined cationic lipid (CL)-mediated delivery of siRNA into mammalian cells and made comparisons to CL-based DNA delivery. The effect of lipid composition and headgroup charge on the biophysical and biological properties of CL-siRNA vectors was determined. X-ray diffraction revealed that CL-siRNA complexes exhibited lamellar and inverted hexagonal phases, qualitatively similar to CL-DNA complexes, but also formed other nonlamellar structures. Surprisingly, optimally formulated inverted hexagonal 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE) CL-siRNA complexes exhibited high toxicity and much lower target-specific gene silencing than lamellar CL-siRNA complexes even though optimally formulated, inverted hexagonal CL-DNA complexes show high transfection efficiency in cell culture. We further found that efficient silencing required cationic lipid/nucleic acid molar charge ratios (rhochg) nearly an order of magnitude larger than those yielding efficiently transfecting CL-DNA complexes. This second unexpected finding has implications for cell toxicity. Multivalent lipids (MVLs) require a smaller number of cationic lipids at a given rhochg of the complex. Consistent with this observation, the pentavalent lipid MVL5 exhibited lower toxicity and superior silencing efficiency over a large range in both the lipid composition and rhochg when compared to monovalent DOTAP. Most importantly, MVL5 achieved much higher total knockdown of the target gene in CL-siRNA complex regimes where toxicity was low. This property of CL-siRNA complexes contrasts to CL-DNA complexes, where the optimized transfection efficiencies of multivalent and monovalent lipids are comparable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391006     DOI: 10.1021/bi062138l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  55 in total

1.  Cationic liposome-nucleic acid complexes: liquid crystal phases with applications in gene therapy.

Authors:  C R Safinya; K K Ewert; Cecília Leal
Journal:  Liq Cryst       Date:  2011-11-22

Review 2.  Effect of surface properties on liposomal siRNA delivery.

Authors:  Yuqiong Xia; Jie Tian; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

3.  Quantitative Intracellular Localization of Cationic Lipid-Nucleic Acid Nanoparticles with Fluorescence Microscopy.

Authors:  Ramsey N Majzoub; Kai K Ewert; Cyrus R Safinya
Journal:  Methods Mol Biol       Date:  2016

4.  Structural evolution of environmentally responsive cationic liposome-DNA complexes with a reducible lipid linker.

Authors:  Rahau S Shirazi; Kai K Ewert; Bruno F B Silva; Cecilia Leal; Youli Li; Cyrus R Safinya
Journal:  Langmuir       Date:  2012-06-06       Impact factor: 3.882

Review 5.  Lipidic systems for in vivo siRNA delivery.

Authors:  Sherry Y Wu; Nigel A J McMillan
Journal:  AAPS J       Date:  2009-09-09       Impact factor: 4.009

6.  Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.

Authors:  Chia-Ling Chan; Kai K Ewert; Ramsey N Majzoub; Yeu-Kuang Hwu; Keng S Liang; Cecília Leal; Cyrus R Safinya
Journal:  J Gene Med       Date:  2014 Mar-Apr       Impact factor: 4.565

Review 7.  Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Authors:  Hanna M G Barriga; Margaret N Holme; Molly M Stevens
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-26       Impact factor: 15.336

8.  Liquid crystal assemblies in biologically inspired systems.

Authors:  Cyrus R Safinya; Joanna Deek; Roy Beck; Jayna B Jones; Cecilia Leal; Kai K Ewert; Youli Li
Journal:  Liq Cryst       Date:  2013-01-01

Review 9.  Lipid-based nanotherapeutics for siRNA delivery.

Authors:  A Schroeder; C G Levins; C Cortez; R Langer; D G Anderson
Journal:  J Intern Med       Date:  2010-01       Impact factor: 8.989

10.  Both helix topology and counterion distribution contribute to the more effective charge screening in dsRNA compared with dsDNA.

Authors:  Suzette A Pabit; Xiangyun Qiu; Jessica S Lamb; Li Li; Steve P Meisburger; Lois Pollack
Journal:  Nucleic Acids Res       Date:  2009-04-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.